Skip to main content
. 2004 Jul 19;2004(3):CD003269. doi: 10.1002/14651858.CD003269.pub2

Petersen 1979.

Methods Crossover design; each phase 3 days
Participants  
Interventions 2 interventions: ipratropium bromide 125µg (nebuliser) and terbutaline 5mg (neb); q.i.d.
Outcomes  
Notes This comparison not analysed, so details not extracted.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Information not available (Cochrane Grade B)